View on market: Stay Cautious, be with quality business:

Equities were mixed in Asia on Wednesday amid warnings about the risk of an economic downturn. Shares rose in Japan and Australia but fell in South Korea. The US futures declined after the S&P 500 and Nasdaq 100 jumped over 2% on Tuesday. As of 6:28 am, the Singapore-traded SGX Nifty — an early barometer of India’s benchmark Nifty 50 — was 0.49% higher at 15,698.50 points. Elsewhere, the yen hovered near 24-year lows against the dollar, due to the dichotomy that is the monetary policy of Bank of Japan and the US Federal Reserve. Crude oil retreated further below $110 a barrel. Bitcoin hovered around $20,000.

Economic Calendar:

  • INR: RBI MPC Minutes on 22nd June 2022.
  • INR: Fiscal Deficit Data 30th June 2022.
  • USD: Core Durable Goods Order 27th June, 2022.
  • USD: Pending Home sales 27th June, 2022.

Brokerage Radar:

GOLDMAN SACHS ON LIC: Initiate Neutral, TP Rs 700 Should benefit from strong structural growth, execution will be key Forecast topline growth to improve to c. 10% (FY22-25E) from 6% in FY19-22, but still trailing industry by 300bps Prvt players much better positioned to O-P.

BoFA SEC ON LIC: Initiate Buy, TP Rs 930 Large room for growth in underinsured market Margin expansion; rising share of non-par & protection Val @ 47-70% disc vs prvt peers Risks: equity market weakness given high EV sensitivity, slower-than-expected margin improvement.

CLSA ON INDUSIND BANK: Buy, TP Rs 1060 Back to improving growth trajectory Better placed on liabilities: this cycle will be a true test; it expect flat margins Asset quality worries behind & credit costs to normalise from FY23CL ROA getting back to 1.8%; no near-term capital raises.

CLSA ON TATA MOTORS: O-P, TP cut to Rs 453 vs Rs 480 Cutting vol est in both JLR & CV biz Stk valuing JLR at 0.5x P/BV Debt likely to come down as free cashflow improves JLR vol decline likely to continue as chip shortage & supply chain bottlenecks continue in CY22.

MORGAN STANLEY ON DR REDDYs: OW, TP Rs 5099 Expects double-digit sales growth to continue, driven by its core biz Reiterated 25% EBITDA & 25% ROCE guidance, driven by operating leverage & productivity gains Plans to be vigilant on capital allocation.

CLSA ON DR REDDY: Buy, TP Rs 4950 Provided more detail on its long-term growth drivers in its key markets of North America, India & EM along with its ongoing productivity enhancement measures Reiterated 25% Ebitda margin/RoCE target.

JEFFERIES ON DR REDDYs: Buy, TP Rs 5036 Re-iterated 25%/25% EBITDA/ROCE targets & elaborated on levers that will help achieve these Aims for sustainable double-digit top-line growth, & plans to expand existing biz & seek new opportunities such as Biologics CDMO & CGT.

JEFFERIES ON RELIANCE: Buy, TP Rs 2950 Correction Offers Opportunity Multi year-low inventories, declining Russian exports, muted Chinese exports, lower diesel production in Europe & delays in commissioning of ME refineries are, tailwinds to refining margins in CY22, Initial estimates suggest RIL could deliver 60% sequential growth in O2C Ebitda in 1QFY23E with likelihood of earnings upgrade Stock has corrected 10% from its recent peak

International Markets:

U.S & Europe:

Particulars      21st June    Chg Chg(%)
Nasdaq 11,069.30 270.95 2.51
Dow 30530.25 641.47 2.15
FTSE 7,152.05 30.24 0.42
CAC 5,964.66 44.57 0.75
DAX 13,292.40 26.8 0.2
Dow Fut.* 30275.00 -257.5 -0.83

Asian markets:

Particulars    22nd June    Chg. Chg(%)
SGX Nifty 15,559.00 -63.5 -0.41
Nikkei 26,255.95 9.64 0.04
Straits Times 3,104.23 -13.25 -0.43
Hang Seng 21,370.58 -189.01 -0.88
Shanghai 3,300.77 -5.95 -0.18

ADR Watch:

Particulars     21st June Chg. Chg.(%)
Dr Reddy 55.84 0.57 1.03
HDFC Bank 55.98 2.5 4.67
ICICI Bank 18.01 0.6 3.45
Infosys 18.77 1.01 5.69
Tata Motor 26.08 0.91 3.62
Wipro 5.49 0.28 5.37

Commodities & Currency:

Particulars Current Price Chg(%)
USD/INR 78.07   0.12
Brent 110.62  -3.55
Gold 1829.50   -0.51
Silver 21.395   -1.73


Particulars     21st June                               20th June
FIIs -2701.21                         -1217.12                       
DIIs  3066.41  2093.39

News Update

Biocon: The company has denied allegations of bribery in drug approval process. That, after PTI reported, citing officials, that the CBI apprehended Joint Drugs Controller S Eswara Reddy for allegedly receiving Rs 4-lakh bribe.

Hero MotoCorp: The company has introduced Euro-V complaint Xpulse 200 4V motorcycle and Dash 110 and Dash 125 scooters in Turkey.

Jain Irrigation: Jain International Trading BV, a wholly owned subsidiary, has agreed to merge its business with Rivulis Pte.

SAIL: The company appointed Anil Kumar Tulsani as director (finance).

Coal India: Adani Enterprises and 10 other companies, including offshore firms, have expressed interest in bidding for coal import tenders floated by India’s biggest miner.

Source: Moneycontrol, Livemint,, Bloomberg, Investing

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited,
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting, or emailing with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website:
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL